Cargando...
Interface of Signal Transduction Inhibition and Immunotherapy in Melanoma
FDA-approved treatment for metastatic melanoma, including interferon alpha and interleukin-2, offer a modest benefit. Immunotherapy, although it has not enjoyed high overall response rates, is capable of providing durable responses in a subset of patients. In recent years, new molecular targeted the...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3229867/ https://ncbi.nlm.nih.gov/pubmed/20693848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3181eb3393 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|